Press Releases

Global Market For Medical Aesthetic Devices To Be Worth $4.8 Billion In 2015

May 03, 2011

Additional Reports


Wellesley, Mass. – According to a new technical market research report, MEDICAL AESTHETIC DEVICES: TECHNOLOGIES AND GLOBAL MARKETS (HLC056A) from BCC Research (, the global market value for medical aesthetic devices was an estimated $3.3 billion in 2010, but is expected to increase to nearly $4.8 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 7.4%.

The largest regional market is that of the United States, which had an estimated value of nearly $1.2 billion in 2010 and is expected to increase at a CAGR of 3.7% to reach nearly $1.4 billion in 2015.

Next is the European market, which is projected to reach more than $1 billion in 2015, after rising at a CAGR of 8.9% from its estimated value of $676 million in 2010.

The third-largest segment is that of China, which was valued at $357 million in 2010 and is expected to rise at a CAGR of 14.3% to reach $696 million in 2015.

The market in Brazil is projected to have an identical 5-year CAGR of 14.3%, increasing from $293 million in 2010 to $572 million in 2015.

Japan is expected to experience negative growth in its medical aesthetics devices market, at a
-3.8% CAGR, to decrease from $166 million in 2010 to $137 million in 2015.

Other significant markets are in India and Mexico.

The key objective of this report is to present a comprehensive analysis of the medical aesthetic devices market for its five largest sectors and to forecast the direction of the global market through 2015.

Recent U.S. Food and Drug Administration (FDA) approvals have expanded the number of medical aesthetic devices available in the U.S. These items have been available elsewhere in the world for many years, social stigmas or the absence of a middle class that can afford them has inhibited their adoption until now.

The expansion of the middle classes in developing economies, shifts in cultural outlooks for developed economies, and regulatory actions in the U.S. have led to a rapidly changing global market for medical aesthetic devices.

This report details the principles of operation, method of manufacture, regulatory restrictions, and current status of the global market for the following medical aesthetic devices:

  • Botulinum neuromodulators for aesthetic applications
  • Breast augmentation devices, including implants and injectable materials
  • Injectable dermal fillers 
  • Devices for assisted liposuction using ultrasound, light, or water
  • Externally-applied energy-emitting devices for: Permanent hair removal, ablative skin resurfacing, non-ablative skin resurfacing, treatment of vascular skin lesions, skin tightening, tattoo removal, acne treatment, treatment of pigmented skin lesions, and cellulite reduction.

The regulatory environment for medical devices and drugs in the U.S. and Europe is described in detail, as it exerts a strong effect on the availability of the devices considered in this report. The properties and characteristics of human skin, hair, and breasts are discussed insofar as they affect device demand.

This study will be of interest to people in the medical device industry, their subcontractors, and their prospective investors; manufacturers of light sources and radiofrequency sources; producers of silicones and related chemicals; producers of the compounds and bacterial organisms necessary to produce dermal fillers and botulinum toxins; medical device importers; and physicians contemplating expansion of their practices to include aesthetic procedures.

To Contact us, click here  help

Source: BCC Research

Medical Aesthetic Devices: Technologies and Global Markets( HLC056A )
Publish Date: Apr 2011    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: as the source and publisher. Thank you.